BioCentury | Jul 23, 2020
Product Development

Encoded to drive first gene therapy into clinic with GV-led $135M series D

...disorder and the three approved treatments -- Epidiolex cannabidiol from GW Pharmaceuticals plc (NASDAQ:GWPH); Diacomit stiripentol...
BioCentury | Jan 5, 2019
Finance

Ready to launch

The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record year...
BioCentury | Aug 31, 2018
Clinical News

FDA approves Biocodex's Diacomit for Dravet syndrome seizures

...FDA approved Diacomit stiripentol from Laboratoires Biocodex (Gentilly, France) to treat seizures associated with Dravet syndrome...
...P450 (p450) inhibitor. Laboratoires Biocodex, Gentilly, France Product: Diacomit stiripentol Business: Neurology Jaime De Leon Diacomit, stiripentol (ME2080) Laboratoires...
BioCentury | Jul 13, 2018
Clinical News

Zogenix to advance regulatory plans on second Phase III win

...Zogenix Inc. (NASDAQ:ZGNX) reported top-line data showing ZX008 as an adjunctive therapy to stiripentol regimen met...
...p<0.005). The double-blind, international trial enrolled 87 patients ages 2-19 on stable background therapy of stiripentol...
...I as an adjunctive therapy for Dravet syndrome. Study 1 did not permit use of stiripentol...
BioCentury | Jul 12, 2018
Clinical News

Zogenix market cap grows with second Phase III win

...in market cap, after it reported top-line data showing ZX008 as an adjunctive therapy to stiripentol...
...p<0.005). The double-blind, international trial enrolled 87 patients ages 2-19 on stable background therapy of stiripentol...
...I as an adjunctive therapy for Dravet syndrome. Study 1 did not permit use of stiripentol...
BioCentury | Apr 30, 2015
Distillery Therapeutics

Therapeutics: Lactate dehydrogenase (LDH)

...Neurology INDICATION: Epilepsy In vitro and mouse studies suggest inhibiting LDHs with stiripentol analogs could help...
...20 approved epilepsy drugs identified stiripentol as an LDH inhibitor. Chemical synthesis and testing of stiripentol...
...additional stiripentol analogs. Laboratoires Biocodex and Meiji Seika Pharma Co. Ltd. market the anticonvulsant Diacomit stiripentol...
BioCentury | Oct 23, 2006
Clinical News

Diacomit stiripentol regulatory update

...CHMP issued a positive opinion on a conditional approval of an MAA for Diacomit to treat...
...Diacomit, an anticonvulsant, has Orphan Drug designation in Europe. Laboratoires Biocodex , Gentilly, France Product: Diacomit...
...an anticonvulsant, has Orphan Drug designation in Europe. Laboratoires Biocodex , Gentilly, France Product: Diacomit stiripentol...
BioCentury | Oct 21, 2006
Top Story

CHMP issues positive opinions

...for GIST and RCC. CHMP issued a positive opinion on a conditional MAA for Diacomit stiripentol...
Items per page:
1 - 8 of 8